[ad_1]
Investing.com – Teva ADR reported on Tuesday first quarter that beat analysts’ forecasts and income that fell wanting expectations.
Teva ADR introduced earnings per share of $0.55 on income of $3.66B. Analysts polled by Investing.com anticipated EPS of $0.5491 on income of $3.74B.
Teva ADR shares are up 6.49% from the start of the yr and are buying and selling at $8.53 , down-from-52-week-high.They’re outperforming the which is down 0% yr thus far.
Teva ADR follows different main Healthcare sector earnings this month
Teva ADR’s report follows an earnings beat by UnitedHealth on Thursday, April 14, 2022, who reported EPS of $5.49 on income of $80.15B, in comparison with forecasts EPS of $5.36 on income of $78.73B.
J&J had beat expectations on Tuesday, April 19, 2022 with first quarter EPS of $2.67 on income of $23.43B, in comparison with forecast for EPS of $2.59 on income of $23.62B.
Keep up-to-date on the entire upcoming earnings stories by visiting Investing.com’s earnings calendar
[ad_2]
Source link